Lv1
10 积分 2025-12-09 加入
Targeting the IRAK1-S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma
15分钟前
已完结
A Glucose Oxidase-Curcumin Composite Nanoreactor for Multimodal Synergistic Cancer Therapy
1个月前
已完结
PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis
11个月前
已完结
Prohibitin regulates mTOR pathway via interaction with FKBP8
11个月前
已完结
Emerging roles of prohibitins in cancer: an update
11个月前
已完结
Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN3-Derived Lipid for Synergistic Lung Cancer Therapy
11个月前
已完结
Identification of PHB2 as a Potential Biomarker of Luminal A Breast Cancer Cells Using a Cell-Specific Aptamer
11个月前
已完结
皖公网安备34019202002308
